Adherence to PoNS device key to improving walking in MS: Study
Oct 10, 2024 · That’s according to early data from PoNSTEP (NCT05437276), a real-world study that’s testing how adherence to the 14-week PoNS therapy regimen reflects on changes in gait, or walking ability ...
How the symptoms of multiple sclerosis affect my hands
Nov 18, 2024 · The opinions expressed in this column are not those of Multiple Sclerosis News Today or its parent company, Bionews, and are intended to spark discussion about issues pertaining to multiple sclerosis.
Let’s talk facts about MS and COVID-19 vaccines – Multiple...
Jun 2, 2023 · Ed's a retired, award-winning broadcast journalist and his column combines his four decades of MS experiences with news and comments about the latest in the MS community.
Multiple Sclerosis News Today | Symptoms, Diagnosis, Treatments
Get the latest multiple sclerosis news, patient views, and caregiver perspectives from one of the largest MS communities online.
About Us - Multiple Sclerosis News Today
Multiple Sclerosis News Today is a digital platform intended to provide the multiple sclerosis (MS) community with the most recent news and information on MS, as well as first-hand community ...
Tecfidera with immune tolerizing cell therapy shows promise for MS
October 8, 2024 News by Esteban Domínguez Cerezo, MS. Nerve stimulator for myelin repair to enter RRMS clinical trial. TolDC therapy found safe, feasible in 2 Phase 1 clinical trials.
Study: MS fatigue can be eased with both modafinil and talk therapy
Oct 21, 2024 · Medicine, talk therapy for fatigue. To find out, the University of Michigan sponsored a clinical trial called COMBO-MS (NCT03621761) that enrolled 336 adults with MS-related fatigue that had been ...
New twin study implicates certain T-cells in early MS inflammation
Oct 9, 2024 · July 30, 2024 News by Marisa Wexler, MS Inflammation outside the brain linked to faster MS progression Study examined CD8 T-cells in 12 pairs of identical twins
Leading Developer Of Cannabis-Based Therapeutics Nemus To …
Feb 9, 2015 · Read About How Nemus Bioscience Aims To Be a Leading Developer Of "Condition-Specific" Cannabinoid-Based Medicines To Address MS and Other Unmet Medical Needs.
PoNS device available to US veterans through new collaboration
Apr 5, 2024 · PoNS device will be available to MS patients in federal healthcare programs. With the new agreement, the device will become available to MS patients in federal healthcare systems, including the ...